Enterome And Takeda To Jointly Mine The Microbiome
This article was originally published in Scrip
Executive Summary
French company Enterome Bioscience S.A. has further expanded its credentials by inking an alliance with Japan's Takeda Pharmaceutical Company Ltd. to research and develop novel therapeutics aimed at microbiome targets thought to play crucial roles in gastrointestinal disorders.